INS and Parkinson disease: Brain iron chelation may act as a general disease-nonspecific mechanism that engages multiple pathways, including downstream effectors of HIF-1α and insulin signaling, to intersect with and possibly slow the progression of multiple human neurological diseases including AD, PD, ischemic stroke, and ICH.